Samsung Biologics' Hanel Hwang, Eunseo (Ency) Lee, Ph.D., and Jungkeun (Henry) Oh discuss how the unique nuances of mRNA production and the inherent fragility of mRNA molecules drive the need for strict ultra-cold chain processes and protocols and a host of specialized capabilities and expertise.
.svg)
